Trials / Completed
CompletedNCT02245555
Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
Observational Study About the Use of Tamsulosin in Patients With Benign Prostatic Hyperplasia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,060 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Study to describe Tamsulosin prescription characteristics in a representative population of patients on treatment for benign prostatic hyperplasia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2007-12-01
- First posted
- 2014-09-19
- Last updated
- 2014-09-19
Source: ClinicalTrials.gov record NCT02245555. Inclusion in this directory is not an endorsement.